Medicare Enrolled

Dr. Sara Dill, MD

Dermatology · Santa Barbara, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
504 W PUEBLO ST STE 102, Santa Barbara, CA 93105
8056823329
In practice since 2006 (19 years)
NPI: 1578573358 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dill? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dill

Dr. Sara Dill is a dermatology specialist in Santa Barbara, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dill performed 3,459 Medicare services across 1,786 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dill received a total of $670,357 from 31 pharmaceutical and/or device companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 36% volume in CA $670,357 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,459
Medicare services
Top 36% in CA for dermatology
1,786
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~182 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,260 $6 $34
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
519 $65 $129
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
374 $38 $147
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
327 $91 $178
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
262 $94 $190
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
211 $66 $174
Ultraviolet light skin treatment
Application of ultraviolet light to the skin for therapeutic purposes.
120 $21 $40
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
73 $1 $3
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
59 $43 $78
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
49 $45 $92
Topical aminolevulinic acid HCl 20% solution
A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient.
41 $306 $615
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
35 $78 $182
Light application with debridement to destroy precancerous skin growth
This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths.
30 $253 $458
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
29 $143 $460
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
22 $40 $103
Destruction of cancer skin growth, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters.
18 $117 $265
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $123 $289
Destruction of skin growth, 15 or more growths 13 $107 $241
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$670,357
Total received (2018-2024)
Avg $95,765/year across 7 years
Top 1% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
497
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$468,847 (69.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$196,231 (29.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,278 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$116,404
2023
$62,722
2022
$48,004
2021
$86,358
2020
$145,244
2019
$99,235
2018
$112,389

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$114,551
Ortho Dermatologics, a division of Bausch Health US, LLC
$334
Janssen Biotech, Inc.
$224
REVANCE THERAPEUTICS, INC.
$162
SUN PHARMACEUTICAL INDUSTRIES INC.
$152
STRATA Skin Sciences, Inc.
$144
Dermavant Sciences, Inc.
$142
PFIZER INC.
$122
E.R. Squibb & Sons, L.L.C.
$106
Verrica Pharmaceuticals Inc.
$98
Galderma Laboratories, L.P.
$76
GENZYME CORPORATION
$69
Incyte Corporation
$45
Lilly USA, LLC
$41
Novartis Pharmaceuticals Corporation
$39
Amgen Inc.
$29
Krystal Biotech Inc
$27
LEO Pharma Inc.
$26
Arcutis Biotherapeutics, Inc.
$16
Top 3 companies account for 98.9% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$232,678
Allergan Inc.
$196,231
ABBVIE INC.
$156,892
AbbVie Inc.
$64,207
Almirall LLC
$15,179
Ortho Dermatologics, a division of Bausch Health US, LLC
$687
Dermavant Sciences, Inc.
$565
Lilly USA, LLC
$415
Novartis Pharmaceuticals Corporation
$369
Janssen Biotech, Inc.
$337
PFIZER INC.
$299
Sun Pharmaceutical Industries Inc.
$293
GENZYME CORPORATION
$272
Regeneron Healthcare Solutions, Inc.
$264
Incyte Corporation
$184
SUN PHARMACEUTICAL INDUSTRIES INC.
$171
REVANCE THERAPEUTICS, INC.
$162
STRATA Skin Sciences, Inc.
$144
DERMIRA, INC.
$130
Celgene Corporation
$129
E.R. Squibb & Sons, L.L.C.
$129
UCB, Inc.
$126
LEO Pharma Inc.
$121
Verrica Pharmaceuticals Inc.
$98
Amgen Inc.
$77
Galderma Laboratories, L.P.
$76
VYNE Pharmaceuticals Inc.
$52
Krystal Biotech Inc
$27
Arcutis Biotherapeutics, Inc.
$16
Biofrontera Inc.
$14
EPI Health, LLC
$10
Top 3 companies account for 87.4% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · BLU-U · BOTOX · BOTOX COSMETIC · CIBINQO · COSENTYX · Cabtreo · Cimzia · DAXXIFY · DUOBRII · DUPIXENT · ENSTILAR · EUCRISA · FINACEA · HUMIRA · ILUMYA · Ilumya · JUBLIA · Klisyri · OPZELURA · Otezla · QBREXZA · REMICADE · SILIQ · SKYRIZI · Sitavig · Sotyktu · TALTZ · TREMFYA · VTAMA · VYJUVEK · Winlevi · XTRAC · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for dermatology in CA.

Looking for a dermatology specialist in Santa Barbara?
Compare dermatologists in the Santa Barbara area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
32
Per 100K population
7.2
County median income
$95,977
Nearest hospital
SANTA BARBARA COTTAGE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dill is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dill experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Dill performed 1,260 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dill receive payments from pharmaceutical companies?
Yes. Dr. Dill received a total of $670,357 from 31 companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dill's costs compare to other dermatologists in Santa Barbara?
Dr. Dill's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →